The invention relates to a traditional Chinese medicinal composition for treating schizophrenosis, which comprises fourteen kinds of Chinese medicinal constituents including (by weight portions):
polygala root 3 parts,
cinnabar 2 parts,
schisandra fruit 2 parts, arborviate seed 3 parts, licorice root 2 parts, lily 3 parts, grassleaved sweetflag
rhizome 4 parts,
arisaema with bile 3 parts, fruit of citron or
trifoliate orange 2 parts, wolfberry fruit 2 parts, amber 2 parts,
banksia rose 3 parts, jujube seeds 3 parts and
curcuma aromatica 3 parts.